123 related articles for article (PubMed ID: 38095597)
1. Performance status as a prognostic surrogate in hepatocellular carcinoma: Role of albumin-bilirubin and easy-albumin-bilirubin grade.
Liao JI; Ho SY; Hou MC; Liu PH; Hsu CY; Huo TI
J Chin Med Assoc; 2024 Feb; 87(2):156-162. PubMed ID: 38095597
[TBL] [Abstract][Full Text] [Related]
2. Prognostic Prediction for Patients with Hepatocellular Carcinoma and Ascites: Role of Albumin-Bilirubin (ALBI) Grade and Easy (EZ)-ALBI Grade.
Liao JI; Ho SY; Liu PH; Hsu CY; Huang YH; Su CW; Hou MC; Huo TI
Cancers (Basel); 2023 Jan; 15(3):. PubMed ID: 36765711
[TBL] [Abstract][Full Text] [Related]
3. Cryptogenic hepatocellular carcinoma: characteristics, outcome, and prognostic role of albumin-bilirubin (ALBI) grade vs easy ALBI grade.
Ho SY; Yuan MH; Liu PH; Hsu CY; Huang YH; Liao JI; Su CW; Wang CL; Hou MC; Huo TI
Scand J Gastroenterol; 2023 Jan; 58(1):61-69. PubMed ID: 35830511
[TBL] [Abstract][Full Text] [Related]
4. Easy albumin-bilirubin score as a new prognostic predictor in hepatocellular carcinoma.
Ho SY; Liu PH; Hsu CY; Ko CC; Huang YH; Su CW; Hsia CY; Tsai PH; Chou SJ; Lee RC; Hou MC; Huo TI
Hepatol Res; 2021 Nov; 51(11):1129-1138. PubMed ID: 34038019
[TBL] [Abstract][Full Text] [Related]
5. Tumor burden score as a new prognostic surrogate in patients with hepatocellular carcinoma undergoing radiofrequency ablation: role of albumin-bilirubin (ALBI) grade vs easy ALBI grade.
Ho SY; Liu PH; Hsu CY; Huang YH; Liao JI; Su CW; Hou MC; Huo TI
Expert Rev Gastroenterol Hepatol; 2022 Sep; 16(9):903-911. PubMed ID: 35999514
[TBL] [Abstract][Full Text] [Related]
6. Validation and prognostic value of EZ-ALBI score in patients with intermediate-stage hepatocellular carcinoma treated with trans-arterial chemoembolization.
Ananchuensook P; Sriphoosanaphan S; Suksawatamnauy S; Siripon N; Pinjaroen N; Geratikornsupuk N; Kerr SJ; Thanapirom K; Komolmit P
BMC Gastroenterol; 2022 Jun; 22(1):295. PubMed ID: 35701739
[TBL] [Abstract][Full Text] [Related]
7. Albumin-Based Liver Reserve Models vs. MELD 3.0 in Prognostic Prediction for Hepatocellular Carcinoma Patients with Renal Insufficiency.
Ho SY; Liu PH; Hsu CY; Tseng HT; Huang YH; Su CW; Hou MC; Huo TI
Int J Mol Sci; 2023 Nov; 24(23):. PubMed ID: 38069310
[TBL] [Abstract][Full Text] [Related]
8. An Albumin-Bilirubin (ALBI) Grade-based Prognostic Model For Patients With Hepatocellular Carcinoma Within Milan Criteria.
Ho SY; Liu PH; Hsu CY; Hsia CY; Su CW; Huang YH; Lei HJ; He YJ; Hou MC; Huo TI
Am J Clin Oncol; 2019 Sep; 42(9):698-704. PubMed ID: 31335351
[TBL] [Abstract][Full Text] [Related]
9. A New Prognostic Model Based on Albumin-Bilirubin Grade for Hepatocellular Carcinoma Beyond the Milan Criteria.
Ho SY; Liu PH; Hsu CY; Hsia CY; Huang YH; Su CW; Lei HJ; Lee RC; Hou MC; Huo TI
Dig Dis Sci; 2020 Feb; 65(2):658-667. PubMed ID: 31659612
[TBL] [Abstract][Full Text] [Related]
10. Comparison of Four Albumin-Based Liver Reserve Models (ALBI/EZ-ALBI/PALBI/PAL) against MELD for Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization.
Ho SY; Liu PH; Hsu CY; Huang YH; Liao JI; Su CW; Hou MC; Huo TI
Cancers (Basel); 2023 Mar; 15(7):. PubMed ID: 37046586
[TBL] [Abstract][Full Text] [Related]
11. Albumin-Bilirubin (ALBI) Grade-Based Nomogram for Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization.
Ho SY; Hsu CY; Liu PH; Lee RC; Ko CC; Huang YH; Su CW; Hou MC; Huo TI
Dig Dis Sci; 2021 May; 66(5):1730-1738. PubMed ID: 32548811
[TBL] [Abstract][Full Text] [Related]
12. Liver Function Assessment Using Albumin-Bilirubin Grade for Patients with Very Early-Stage Hepatocellular Carcinoma Treated with Radiofrequency Ablation.
Oh IS; Sinn DH; Kang TW; Lee MW; Kang W; Gwak GY; Paik YH; Choi MS; Lee JH; Koh KC; Paik SW
Dig Dis Sci; 2017 Nov; 62(11):3235-3242. PubMed ID: 28983724
[TBL] [Abstract][Full Text] [Related]
13. Survival of Patients with Hepatocellular Carcinoma in Renal Insufficiency: Prognostic Role of Albumin-Bilirubin Grade.
Ho SY; Hsu CY; Liu PH; Ko CC; Huang YH; Su CW; Lee RC; Hou MC; Huo TI
Cancers (Basel); 2020 Apr; 12(5):. PubMed ID: 32366000
[TBL] [Abstract][Full Text] [Related]
14. Albumin-bilirubin grade-based nomogram of the BCLC system for personalized prognostic prediction in hepatocellular carcinoma.
Ho SY; Hsu CY; Liu PH; Hsia CY; Lei HJ; Huang YH; Ko CC; Su CW; Lee RC; Hou MC; Huo TI
Liver Int; 2020 Jan; 40(1):205-214. PubMed ID: 31505104
[TBL] [Abstract][Full Text] [Related]
15. Dual hepatitis B and C-associated hepatocellular carcinoma: clinical characteristics, outcome, and prognostic role of albumin-bilirubin grade.
Ko CC; Ho SY; Liu PH; Hsu CY; Hsia CY; Huang YH; Su CW; Lei HJ; Lee RC; Hou MC; Huo TI
Int J Clin Oncol; 2022 Apr; 27(4):739-748. PubMed ID: 35119581
[TBL] [Abstract][Full Text] [Related]
16. The role of preoperative albumin-bilirubin grade for oncological risk stratification in liver transplant patients with hepatocellular carcinoma.
Kornberg A; Witt U; Schernhammer M; Kornberg J; Müller K; Friess H; Thrum K
J Surg Oncol; 2019 Dec; 120(7):1126-1136. PubMed ID: 31578753
[TBL] [Abstract][Full Text] [Related]
17. Albumin-bilirubin (ALBI) grade-based nomogram to predict tumor recurrence in patients with hepatocellular carcinoma.
Ho SY; Hsu CY; Liu PH; Hsia CY; Su CW; Huang YH; Hou MC; Huo TI
Eur J Surg Oncol; 2019 May; 45(5):776-781. PubMed ID: 30401507
[TBL] [Abstract][Full Text] [Related]
18. The role of albumin-bilirubin grade in determining the outcomes of patients with very early-stage hepatocellular carcinoma.
Chang CY; Wei CY; Chen PH; Hou MC; Chao Y; Chau GY; Lee RC; Huang YH; Su YH; Wu JC; Su CW
J Chin Med Assoc; 2021 Feb; 84(2):136-143. PubMed ID: 33433133
[TBL] [Abstract][Full Text] [Related]
19. Neutrophil to lymphocyte ratio and albumin bilirubin grade in hepatocellular carcinoma: A systematic review.
Bannaga A; Arasaradnam RP
World J Gastroenterol; 2020 Sep; 26(33):5022-5049. PubMed ID: 32952347
[TBL] [Abstract][Full Text] [Related]
20. Postoperative Albumin-Bilirubin Grade Change Predicts the Prognosis of Patients with Hepatitis B-Related Hepatocellular Carcinoma Within the Milan Criteria.
Li C; Zhang XY; Peng W; Wen TF; Yan LN; Li B; Yang JY; Wang WT; Xu MQ
World J Surg; 2018 Jun; 42(6):1841-1847. PubMed ID: 29138913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
